Go Pro
Oppenheimer

Oppenheimer Analyst Recommendations & Stock Picks (NYSE:OPY)

View the latest stock recommendations issued by analysts at Oppenheimer. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Oppenheimer's equity research team. MarketBeat is not affiliated with or endorsed by Oppenheimer.

  • 85 Broad Street, 22nd Floor, New York, NY, 10004
  • Finance
  • 50 Analysts
  • Website
  • Updated 9/25/2026
Average Return
00.00% 12-Month ROI
Total Ratings
1,356 Last 12 Months
Buy Ratings
1,130 Last 12 Months
Sell Ratings
5 Last 12 Months
Companies Covered
558 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
$14.40
-0.1%
9/25/2026Reiterated RatingOutperformView details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 9/25/2026
Okta, Inc. stock logo
OKTA
Okta
$202.18
+3.6%
9/24/2026Boost Price Target$190.00 ➝ $227.00OutperformView details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 9/24/2026
Knife River Corporation stock logo
KNF
Knife River
$53.41
-2.1%
9/24/2026Lower Price Target$90.00 ➝ $80.00OutperformView details for Oppenheimer rating of Knife River (NYSE:KNF) on 9/24/2026
Corteva, Inc. stock logo
CTVA
Corteva
$77.71
-1.0%
9/24/2026Reiterated Rating$95.00OutperformView details for Oppenheimer rating of Corteva (NYSE:CTVA) on 9/24/2026
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
$40.01
-3.0%
9/24/2026Reiterated RatingOutperformView details for Oppenheimer rating of Harmony Biosciences (NASDAQ:HRMY) on 9/24/2026
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$45.57
+2.4%
9/24/2026Reiterated Rating$85.00OutperformView details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/24/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$57.85
-0.2%
9/24/2026Boost Price Target$60.00 ➝ $71.00OutperformView details for Oppenheimer rating of Dynatrace (NYSE:DT) on 9/24/2026
McDonald's Corporation stock logo
MCD
McDonald's
$233.32
-1.3%
9/24/2026 Lower Price Target$325.00 ➝ $295.00OutperformView details for Oppenheimer rating of McDonald’s (NYSE:MCD) on 9/24/2026
NIKE, Inc. stock logo
NKE
NIKE
$36.40
+1.8%
9/23/2026Set Price Target$60.00 ➝ $52.00OutperformView details for Oppenheimer rating of NIKE (NYSE:NKE) on 9/23/2026
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
$20.50
+3.7%
9/23/2026Initiated Coverage$27.00OutperformView details for Oppenheimer rating of Amneal Pharmaceuticals (NASDAQ:AMRX) on 9/23/2026
Viatris Inc. stock logo
VTRS
Viatris
$18.27
+2.5%
9/23/2026Initiated Coverage$25.00OutperformView details for Oppenheimer rating of Viatris (NASDAQ:VTRS) on 9/23/2026
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$74.83
+1.1%
9/23/2026Initiated Coverage$85.00Market PerformView details for Oppenheimer rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 9/23/2026
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$5.17
+2.4%
9/23/2026Initiated Coverage$10.00OutperformView details for Oppenheimer rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 9/23/2026
AutoZone, Inc. stock logo
AZO
AutoZone
$2,917.83
+1.6%
9/23/2026Set Price Target$3,400.00View details for Oppenheimer rating of AutoZone (NYSE:AZO) on 9/23/2026
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$20.53
-0.7%
9/23/2026Reiterated RatingMarket PerformView details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 9/23/2026
Amgen Inc. stock logo
AMGN
Amgen
$418.13
+0.8%
9/23/2026Reiterated RatingOutperformView details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 9/23/2026
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
$22.63
+0.4%
9/23/2026Initiated Coverage$50.00OutperformView details for Oppenheimer rating of Collegium Pharmaceutical (NASDAQ:COLL) on 9/23/2026
CorMedix Inc stock logo
CRMD
CorMedix
$7.89
+0.5%
9/23/2026Initiated Coverage$15.00OutperformView details for Oppenheimer rating of CorMedix (NASDAQ:CRMD) on 9/23/2026
Innoviva, Inc. stock logo
INVA
Innoviva
$21.23
+2.4%
9/23/2026Initiated Coverage$35.00OutperformView details for Oppenheimer rating of Innoviva (NASDAQ:INVA) on 9/23/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$25.39
+1.1%
9/23/2026Initiated Coverage$32.00OutperformView details for Oppenheimer rating of Pacira BioSciences (NASDAQ:PCRX) on 9/23/2026
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$38.84
-0.9%
9/23/2026Initiated Coverage$50.00OutperformView details for Oppenheimer rating of Teva Pharmaceutical Industries (NYSE:TEVA) on 9/23/2026
Toro Company (The) stock logo
TTC
Toro
$97.05
-0.1%
9/23/2026Initiated Coverage$120.00OutperformView details for Oppenheimer rating of Toro (NYSE:TTC) on 9/23/2026
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$33.03
-7.1%
9/22/2026 Set Price Target$120.00View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 9/22/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$21.45
-1.4%
9/22/2026Reiterated Rating$50.00 ➝ $40.00OutperformView details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 9/22/2026
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$1.08
9/22/2026Lower Price Target$5.00OutperformView details for Oppenheimer rating of Connect Biopharma (NASDAQ:CNTB) on 9/22/2026
KBR, Inc. stock logo
KBR
KBR
$34.78
+0.7%
9/22/2026Lower Price Target$60.00 ➝ $50.00OutperformView details for Oppenheimer rating of KBR (NYSE:KBR) on 9/22/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$509.22
-1.3%
9/22/2026Boost Price Target$515.00 ➝ $570.00OutperformView details for Oppenheimer rating of Microsoft (NASDAQ:MSFT) on 9/22/2026
Coherent Corp. stock logo
COHR
Coherent
$282.57
-4.5%
9/22/2026 UpgradeOutperform ➝ BuyView details for Oppenheimer rating of Coherent (NYSE:COHR) on 9/22/2026
Turning Point Brands, Inc. stock logo
TPB
Turning Point Brands
$60.65
-2.3%
9/22/2026Lower Price Target$130.00 ➝ $90.00OutperformView details for Oppenheimer rating of Turning Point Brands (NYSE:TPB) on 9/22/2026
Tesla, Inc. stock logo
TSLA
Tesla
$357.45
-3.9%
9/21/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 9/21/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$44.11
+0.4%
9/21/2026Lower Price Target$85.00 ➝ $65.00OutperformView details for Oppenheimer rating of Boston Scientific (NYSE:BSX) on 9/21/2026
Amrize Ltd stock logo
AMRZ
Amrize
$38.11
-0.3%
9/18/2026Lower Price Target$62.00 ➝ $55.00OutperformView details for Oppenheimer rating of Amrize (NYSE:AMRZ) on 9/18/2026
AutoZone, Inc. stock logo
AZO
AutoZone
$2,917.83
+1.6%
9/18/2026Lower Price Target$4,300.00 ➝ $3,500.00OutperformView details for Oppenheimer rating of AutoZone (NYSE:AZO) on 9/18/2026
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$8.71
+4.2%
9/17/2026 Reiterated RatingOutperformView details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/17/2026
Jefferies Financial Group Inc. stock logo
JEF
Jefferies Financial Group
$47.15
-1.1%
9/17/2026Reiterated Rating$76.00OutperformView details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 9/17/2026
Kopin Corporation stock logo
KOPN
Kopin
$4.75
-4.8%
9/17/2026Initiated Coverage$7.00OutperformView details for Oppenheimer rating of Kopin (NASDAQ:KOPN) on 9/17/2026
Salesforce Inc. stock logo
CRM
Salesforce
$227.17
-2.9%
9/17/2026Reiterated RatingOutperformView details for Oppenheimer rating of Salesforce (NYSE:CRM) on 9/17/2026
Costco Wholesale Corporation stock logo
COST
Costco Wholesale
$922.92
+0.0%
9/16/2026Reiterated Rating$1,160.00OutperformView details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 9/16/2026
Forgent Power Solutions, Inc. stock logo
FPS
Forgent Power Solutions
$36.53
-6.3%
9/16/2026Reiterated Rating$60.00OutperformView details for Oppenheimer rating of Forgent Power Solutions (NYSE:FPS) on 9/16/2026
James Hardie Industries PLC. stock logo
JHX
James Hardie Industries
$25.42
-2.6%
9/16/2026Reiterated Rating$36.00OutperformView details for Oppenheimer rating of James Hardie Industries (NYSE:JHX) on 9/16/2026
Major Buy Alert Issued for September 30th (Ad)

Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.tc pixel

See which stocks his AI research platform is flagging now
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$35.13
-3.4%
9/15/2026Initiated Coverage$53.00OutperformView details for Oppenheimer rating of Astrana Health (NASDAQ:ASTH) on 9/15/2026
Vishay Intertechnology, Inc. stock logo
VSH
Vishay Intertechnology
$32.25
-0.9%
9/15/2026Initiated Coverage$42.00OutperformView details for Oppenheimer rating of Vishay Intertechnology (NYSE:VSH) on 9/15/2026
Etsy Inc stock logo
ETSY
Etsy
$68.94
+0.7%
9/15/2026Upgrade$90.00Market Perform ➝ OutperformView details for Oppenheimer rating of Etsy (NYSE:ETSY) on 9/15/2026
Darden Restaurants, Inc. stock logo
DRI
Darden Restaurants
$197.11
-1.3%
9/15/2026Boost Price Target$235.00 ➝ $245.00OutperformView details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 9/15/2026
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
$38.41
+6.2%
9/14/2026Reiterated Rating$75.00OutperformView details for Oppenheimer rating of Definium Therapeutics (NASDAQ:DFTX) on 9/14/2026
Roblox Corporation stock logo
RBLX
Roblox
$41.88
-9.8%
9/11/2026Reiterated RatingOutperformView details for Oppenheimer rating of Roblox (NYSE:RBLX) on 9/11/2026
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$98.49
-5.7%
9/10/2026Initiated Coverage$120.00OutperformView details for Oppenheimer rating of Aehr Test Systems (NASDAQ:AEHR) on 9/10/2026
Apple Inc. stock logo
AAPL
Apple
$338.40
-0.8%
9/10/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 9/10/2026
Skillsoft Corp. stock logo
SKIL
Skillsoft
$5.97
+0.4%
9/10/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of Skillsoft (NYSE:SKIL) on 9/10/2026
Zurn Elkay Water Solutions Cor stock logo
ZWS
Zurn Elkay Water Solutions Cor
$46.77
+0.3%
9/9/2026Boost Price Target$58.00 ➝ $60.00OutperformView details for Oppenheimer rating of Zurn Elkay Water Solutions Cor (NYSE:ZWS) on 9/9/2026
Ralliant Corporation stock logo
RAL
Ralliant
$69.88
-0.2%
9/9/2026Boost Price Target$75.00 ➝ $80.00OutperformView details for Oppenheimer rating of Ralliant (NYSE:RAL) on 9/9/2026
IDEX Corporation stock logo
IEX
IDEX
$231.34
+0.5%
9/9/2026Boost Price Target$265.00 ➝ $270.00OutperformView details for Oppenheimer rating of IDEX (NYSE:IEX) on 9/9/2026
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$90.29
-3.6%
9/9/2026Boost Price Target$141.00 ➝ $145.00OutperformView details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 9/9/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$17.25
+0.3%
9/9/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of PROCEPT BioRobotics (NASDAQ:PRCT) on 9/9/2026
Aktis Oncology stock logo
AKTS
Aktis Oncology
$19.35
-0.4%
9/9/2026Initiated Coverage$40.00OutperformView details for Oppenheimer rating of Aktis Oncology (NASDAQ:AKTS) on 9/9/2026
Aktis Oncology stock logo
AKTS
Aktis Oncology
$19.35
-0.4%
9/9/2026Initiated Coverage$40.00OutperformView details for Oppenheimer rating of Aktis Oncology (NASDAQ:AKTS) on 9/9/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$10.52
-1.3%
9/9/2026 Set Price Target$5.00View details for Oppenheimer rating of Ginkgo Bioworks (NYSE:DNA) on 9/9/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$5.05
+6.1%
9/9/2026Boost Price Target$10.00 ➝ $20.00OutperformView details for Oppenheimer rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$31.91
-0.3%
9/8/2026 Reiterated Rating$75.00OutperformView details for Oppenheimer rating of Pharvaris (NASDAQ:PHVS) on 9/8/2026
Enphase Energy, Inc. stock logo
ENPH
Enphase Energy
$30.91
-4.6%
9/8/2026Reiterated RatingOutperformView details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 9/8/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$11.74
+0.7%
9/8/2026Boost Price Target$18.00 ➝ $25.00OutperformView details for Oppenheimer rating of Climb Bio (NASDAQ:CLYM) on 9/8/2026
Target Hospitality Corp. stock logo
TH
Target Hospitality
$19.30
-6.2%
9/8/2026Boost Price Target$24.00 ➝ $27.00OutperformView details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 9/8/2026
Take-Two Interactive Software, Inc. stock logo
TTWO
Take-Two Interactive Software
$202.35
+0.5%
9/8/2026Reiterated RatingOutperformView details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 9/8/2026
Adobe Inc. stock logo
ADBE
Adobe
$231.01
-1.9%
9/8/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/8/2026
Oracle Corporation stock logo
ORCL
Oracle
$132.64
-3.3%
9/8/2026Reiterated Rating$235.00 ➝ $275.00OutperformView details for Oppenheimer rating of Oracle (NYSE:ORCL) on 9/8/2026
UiPath, Inc. stock logo
PATH
UiPath
$12.23
-1.9%
9/4/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of UiPath (NYSE:PATH) on 9/4/2026
Ambarella, Inc. stock logo
AMBA
Ambarella
$68.68
-5.5%
9/4/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of Ambarella (NASDAQ:AMBA) on 9/4/2026
Guidewire Software, Inc. stock logo
GWRE
Guidewire Software
$144.81
-0.5%
9/4/2026Boost Price Target$200.00 ➝ $210.00OutperformView details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 9/4/2026
Snowflake Inc. stock logo
SNOW
Snowflake
$328.33
-2.3%
9/3/2026Boost Price Target$400.00 ➝ $475.00OutperformView details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 9/3/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
$8.73
-2.3%
9/3/2026 Reiterated RatingMarket PerformView details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 9/3/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$392.09
+4.6%
9/2/2026Reiterated Rating$400.00 ➝ $450.00OutperformView details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 9/2/2026
Alumis Inc. stock logo
ALMS
Alumis
$7.16
+0.8%
9/2/2026Lower Price Target$55.00 ➝ $37.00OutperformView details for Oppenheimer rating of Alumis (NASDAQ:ALMS) on 9/2/2026
SpaceX stock logo
SPCX
SpaceX
$145.47
-2.2%
9/2/2026Boost Price Target$250.00 ➝ $280.00OutperformView details for Oppenheimer rating of SpaceX (NASDAQ:SPCX) on 9/2/2026
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$230.05
+2.0%
9/1/2026Boost Price Target$304.00 ➝ $312.00OutperformView details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/1/2026
RingCentral, Inc. stock logo
RNG
RingCentral
$76.04
-0.2%
9/1/2026Boost Price Target$50.00 ➝ $85.00OutperformView details for Oppenheimer rating of RingCentral (NYSE:RNG) on 9/1/2026
Timken Company (The) stock logo
TKR
Timken
$116.83
-0.5%
9/1/2026Set Price Target$135.00View details for Oppenheimer rating of Timken (NYSE:TKR) on 9/1/2026
Tectonic Therapeutic, Inc. stock logo
TECX
Tectonic Therapeutic
$23.51
-0.7%
9/1/2026 Reiterated RatingOutperformView details for Oppenheimer rating of Tectonic Therapeutic (NASDAQ:TECX) on 9/1/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$67.21
-6.0%
8/28/2026Boost Price Target$100.00 ➝ $104.00OutperformView details for Oppenheimer rating of Affirm (NASDAQ:AFRM) on 8/28/2026
Elastic N.V. stock logo
ESTC
Elastic
$88.21
+0.1%
8/28/2026Boost Price Target$100.00 ➝ $118.00OutperformView details for Oppenheimer rating of Elastic (NYSE:ESTC) on 8/28/2026
Marvell Technology, Inc. stock logo
MRVL
Marvell Technology
$251.90
-3.8%
8/28/2026Boost Price Target$300.00 ➝ $325.00OutperformView details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 8/28/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$201.74
-1.6%
8/27/2026Boost Price Target$230.00 ➝ $260.00OutperformView details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 8/27/2026
Navan, Inc. stock logo
NAVN
Navan
$19.98
+2.9%
8/27/2026Boost Price Target$30.00 ➝ $35.00OutperformView details for Oppenheimer rating of Navan (NASDAQ:NAVN) on 8/27/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$228.86
+1.7%
8/27/2026Set Price Target$265.00 ➝ $315.00OutperformView details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 8/27/2026
Salesforce Inc. stock logo
CRM
Salesforce
$227.17
-2.9%
8/27/2026Reiterated Rating$250.00 ➝ $275.00OutperformView details for Oppenheimer rating of Salesforce (NYSE:CRM) on 8/27/2026
Ares Management Corporation stock logo
ARES
Ares Management
$118.43
-2.9%
8/27/2026Boost Price Target$151.00 ➝ $162.00OutperformView details for Oppenheimer rating of Ares Management (NYSE:ARES) on 8/27/2026
Braze, Inc. stock logo
BRZE
Braze
$23.17
-4.9%
8/27/2026Boost Price Target$30.00 ➝ $36.00OutperformView details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 8/27/2026
Blackstone Inc. stock logo
BX
Blackstone
$114.52
-3.3%
8/27/2026Boost Price Target$140.00 ➝ $171.00OutperformView details for Oppenheimer rating of Blackstone (NYSE:BX) on 8/27/2026
Hamilton Lane Inc. stock logo
HLNE
Hamilton Lane
$84.96
-1.4%
8/27/2026Lower Price Target$182.00 ➝ $181.00OutperformView details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 8/27/2026
KKR & Co. Inc. stock logo
KKR
KKR & Co. Inc.
$93.16
-3.6%
8/27/2026Boost Price Target$139.00 ➝ $166.00OutperformView details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 8/27/2026
Nutanix stock logo
NTNX
Nutanix
$68.70
+1.0%
8/27/2026Boost Price Target$80.00 ➝ $85.00OutperformView details for Oppenheimer rating of Nutanix (NASDAQ:NTNX) on 8/27/2026
Major Buy Alert Issued for September 30th (Ad)

Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.tc pixel

See which stocks his AI research platform is flagging now
Okta, Inc. stock logo
OKTA
Okta
$202.18
+3.6%
8/27/2026Boost Price Target$170.00 ➝ $190.00OutperformView details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 8/27/2026
Blue Owl Capital Inc. stock logo
OWL
Blue Owl Capital
$9.15
-1.9%
8/27/2026Boost Price Target$15.00 ➝ $17.00OutperformView details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 8/27/2026
Ridgepost Capital, Inc stock logo
RPC
Ridgepost Capital
$7.35
-2.6%
8/27/2026Lower Price Target$16.00 ➝ $15.00OutperformView details for Oppenheimer rating of Ridgepost Capital (NYSE:RPC) on 8/27/2026
StepStone Group Inc. stock logo
STEP
StepStone Group
$43.11
-2.8%
8/27/2026Lower Price Target$90.00 ➝ $88.00OutperformView details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 8/27/2026
DICK'S Sporting Goods, Inc. stock logo
DKS
DICK'S Sporting Goods
$134.45
-1.5%
8/26/2026Lower Price Target$270.00 ➝ $150.00OutperformView details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 8/26/2026
WisdomTree, Inc. stock logo
WT
WisdomTree
$24.12
-0.9%
8/26/2026Boost Price Target$22.00 ➝ $27.00OutperformView details for Oppenheimer rating of WisdomTree (NYSE:WT) on 8/26/2026
Intuit Inc. stock logo
INTU
Intuit
$269.40
-2.3%
8/26/2026Lower Price Target$406.00 ➝ $380.00OutperformView details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 8/26/2026
Walmart Inc. stock logo
WMT
Walmart
$108.73
+0.7%
8/25/2026Reiterated RatingMarket PerformView details for Oppenheimer rating of Walmart (NASDAQ:WMT) on 8/25/2026
Dollar General Corporation stock logo
DG
Dollar General
$124.50
-0.3%
8/25/2026Reiterated Rating$150.00OutperformView details for Oppenheimer rating of Dollar General (NYSE:DG) on 8/25/2026
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$8.71
+4.2%
8/25/2026 UpgradeMarket Perform ➝ OutperformView details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 8/25/2026

MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms in the last 90 days. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Oppenheimer's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Oppenheimer's equity research team has issued ratings on 556 companies across 11 sectors over the past 12 months, covered by 50 analysts. The Oppenheimer analysts below are listed by number of ratings issued in the last year.

Oppenheimer Stock Coverage by Sector

Oppenheimer concentrates its research most heavily in Healthcare (30.1%), Technology (22.0%) and Industrials (16.5%). The chart below shows how Oppenheimer's 558 rated companies are distributed across all 11 sectors it covers.

Oppenheimer - Frequently Asked Questions

Oppenheimer's analysts currently have buy-equivalent ratings on 467 companies. Recent upgrades to buy include Coherent, Etsy, Capricor Therapeutics, Intuitive Surgical and Inspire Medical Systems.

Oppenheimer's highest-rated analysts by MarketBeat's accuracy score include Leland Gershell, Matthew Biegler and Jeff Jones. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 52 analysts at Oppenheimer.

Oppenheimer has the deepest coverage in Healthcare (30.1% of rated companies), Technology (22.0% of rated companies), Industrials (16.5% of rated companies), Finance (9.9% of rated companies) and Consumer Discretionary (9.5% of rated companies).

Oppenheimer issued 1,356 ratings over the last 12 months across 558 companies — an average of roughly 113 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Oppenheimer analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Oppenheimer uses Outperform, Perform, and Underperform as their equivalents.